I Got My Life Back: Patients in Pain Tell Their Story

I Got My Life Back: Patients in Pain Tell Their Story was a Purdue video promoting OxyContin by emphasizing patients’ quality of life while minimizing the drug’s risks. By circulating the video through doctors’ offices without submitting it for required U.S. Food and Drug Administration review, Purdue gave clinical authority and a repeated claim about addiction risk a prominent role in its sales-era messaging.

Production and Distribution

By the end of 2000, Purdue had distributed 15,000 copies of the video. Doctors’ offices made it available for checkout, extending its reach beyond a single promotional presentation and placing its message in settings where patients and clinicians sought information about pain treatment.

The video’s format joined accounts of patients in pain to a reassuring presentation of OxyContin. It praised the drug’s effect on quality of life and minimized potential harms. The result was not simply a record of patient experience: it also served as a vehicle for Purdue’s argument about how opioid-seeking behavior should be understood.

The Video’s Account of Addiction

The doctor-narrator advanced the term pseudo addiction to describe patients who appeared to seek drugs but, in this account, were actually pursuing relief from pain. That framing recast behavior that might be read as a sign of addiction as evidence of undertreated pain. The narrator also repeated the claim that opioid analgesics caused addiction in fewer than one percent of patients.

That statistic came from a one-paragraph 1980 letter to the editor of the New England Journal of Medicine. One of the letter’s authors later explained that it had never been intended as a conclusion about the risks of long-term opiate use. The distance between the limited source and the broad claim used in the video is central to the book’s account of how an assurance about addiction risk acquired authority.

Repetition Beyond the Video

The claim did not remain confined to the video. At Dine ’n’ Dash gatherings and in doctors’ offices, from the coalfields to the California coast, the letter’s contents were repeated and altered. In the book’s account, each retelling carried the claim farther from the authors’ original intention, like a game of telephone in which the message changed as it spread.

The video therefore belongs to a wider promotional and professional discourse, rather than standing as an isolated artifact. Its claims gained force through repetition across settings, where the distinction between a brief letter and evidence about long-term opioid use could disappear. The video’s circulation helped make a qualified and misapplied statistic sound like a general assurance.

A Subsequent Extension of Its Argument

A year after appearing in the Purdue video, South Carolina pain specialist Dr. Alan Spanos lectured that patients with chronic noncancer pain should be trusted to decide how many painkillers they could take without overdosing. He reasoned that they would fall asleep before their breathing stopped. This was a later lecture, not a scene from the video, but its argument extended the confidence in patient self-regulation that the book traces through the promotion of OxyContin.

The book places that reasoning in historical perspective by comparing it with the views of doctors who dispensed morphine to wounded veterans after the Civil War. In that longer arc, the video’s importance lies not only in its 15,000 copies or its place in doctors’ offices, but in how it packaged reassurance: an account of pain relief, a language for reinterpreting apparent drug-seeking, and a statistic whose original limits were no longer visible in its repeated use.